Job Description Summary
Sustain and extend GE HealthCare’s global leadership in contrast media, and build the marketing engine that carries the business into its next generation of products. The Chief Marketing Officer, Contrast Media is the global owner of downstream marketing for the largest portfolio in Pharmaceutical Diagnostics segment, accountable for the global strategy creating the standards, capabilities and operating rhythm that enable regions to execute with speed, consistency and local relevance.
Sustain and extend GE HealthCare’s global leadership in contrast media, and build the marketing engine that carries the business into its next generation of products. The Chief Marketing Officer, Contrast Media is the global owner of downstream marketing for the largest portfolio in Pharmaceutical Diagnostics segment, accountable for the global strategy creating the standards, capabilities and operating rhythm that enable regions to execute with speed, consistency and local relevance.
Job Description
this role is open to qualified applicants across eligible GE HealthCare locations worldwide
Key Responsibilities
Global Strategy, Portfolio and Insight
- Own the global downstream marketing strategy for contrast media across all geographies, translating segment objectives into an integrated brand, demand generation and market access agenda.
- Lead the marketing components of Worldwide Product Planning (WWPP) and Long Term Strategy (LTS) for Contrast Media, directing global market research and competitive intelligence and consolidating it with the voice of region and of the customer.
- Own global brand positioning, segmentation, targeting and messaging architecture; approve regional adaptations and enforce consistency of claims and identity worldwide.
- Provide key inputs into Strategy Reviews and resource planning — market sizing, forecasting, share models and investment requirements — and allocate global downstream budget across brands, regions and channels.
Mature Brand Defense and Lifecycle Management
- Own the global defense strategy for a portfolio facing generic and low-cost competition: value articulation, share retention, volume growth and disciplined price and tender positioning in partnership with market access and pricing.
- Build the evidence-to-message chain that sustains premium preference — patient safety, dose and workflow efficiency, supply reliability, sustainability and total cost of care — working with medical affairs and health economics.
- Lead lifecycle management: indication and presentation expansion, packaging and delivery-system innovation, injector and digital ecosystem tie-ins, and portfolio rationalization (LEAN) where SKUs no longer earn their place.
New Product Launch Readiness and Market Preparation
- Own global downstream launch readiness for the new contrast agents entering the portfolio, from pre-launch market shaping through launch execution and the first years on market.
- Build and run the market preparation agenda ahead of approval: disease- and pathway-level education, unmet-need framing, referral and protocol mapping, KOL and advocacy engagement with medical affairs and professional societies, and payer and reimbursement pathway development with market access.
- Equip commercial teams with the knowledge, materials and tools required at launch, and build a repeatable launch capability that outlasts this launch.
Digital, Data and Standardization
- Continue the shift of the business from a field-led model to a digital-first, omni-channel model — owning channel strategy and the customer journey across web, search, email, social, virtual, congress and field-enabled digital.
- Own the martech platform strategy and tool management for Contrast Media: CRM and marketing automation integration
#J-18808-Ljbffr…